The Health Care M&A Monthly: CSL Buys Talecris Biotherapeutics–
Pays $3.1 Billion To Bolster Plasma Derivatives Business Email this article to a friend Email Editor The largest deal to be announced in August reflects several current trends in the health care M&A market. It shows us how the biotech industry is broadening...The SeniorCare Investor: Occupancy Bottom Nearing–
After a Mixed Quarter, Providers See Occupancy Uptick Just as it looked like the seniors housing stock market was going to fall into an even larger hole, some positive news resulted in the best monthly performance for the sector this year, if not ever. In addition,...The SeniorCare Investor: Prices Down, Cap Rates Up–
Mid-Year Data Confirm Market Suspicions About Trends For the past 12 months, ever since the subprime mortgage market blew up in the summer of 2007, the seniors housing and care acquisition market entered into a new phase, and one that not many people were happy...Senior Living Business: PACE Programs Address Both Mission & Margin–
On Lok In San Francisco, The First PACE Center, Expanding Again The On Lok Senior Health Center in San Francisco opened back in the early 1970s in response to a local need — and that move, in a sense, redefined quality senior health care. At the time, the mostly...Senior Living Business: Let’s Talk Fannie Mae And Freddie Mac…
What’s The Impact On Senior Housing? A Credit Crisis Worsening? Rest assured, Fannie Mae and Freddie Mac are still open for business on seniors housing deals, albeit with higher spreads and more caution. Their senior housing portfolios remain very strong with no...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
